Pharmaceutical

Venture Medical Issues Statement on CMS 2026 Physician Fee Schedule Final Rule

Company reaffirms its commitment to patient access, clinical excellence, and responsible reimbursement reform under the new CMS framework. MISSOULA, MT…

2 months ago

Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership

PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / November 6, 2025 / Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail Partners, LLC…

2 months ago

Pharmacovigilance Market to Reach $26.2 billion, Globally, by 2034 at 12.3% CAGR: Allied Market Research

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role…

2 months ago

PhaseV Earns Three Prestigious Industry Awards Highlighting Leadership in AI for Clinical Development

Company Included in CB Insights' Digital Health 50 List, TechCrunch's AI Disruptors 60 List and Named BioTech Breakthrough 'Analytics Solution…

2 months ago

Evogene Schedules Third Quarter 2025 Financial Results Release

Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd.…

2 months ago

Verseon’s Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences

One paper presented at IEEE International Conference on Future Machine Learning and Data Science 2025 covers Verseon's superior predictions of…

2 months ago

Using Early Real-world Evidence Generation to Drive Commercial Success, Upcoming Webinar with Sciensus, Hosted by Xtalks

In this free webinar, explore the strategic value of early real-world evidence generation in biotech development, focusing on what data…

2 months ago

Enhance Peptide Manufacturing Using Backbone N-Protecting Groups, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn backbone protecting group strategies for overcoming difficulties during solid-phase peptide synthesis and solution-phase handling. The…

2 months ago

Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in…

2 months ago

Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.

DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies…

2 months ago